These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31060598)

  • 1. RNA sequencing of mesenchymal stem cells reveals a blocking of differentiation and immunomodulatory activities under inflammatory conditions in rheumatoid arthritis patients.
    Lamas JR; Fernandez-Gutierrez B; Mucientes A; Marco F; Lopiz Y; Jover JA; Abasolo L; Rodríguez-Rodríguez L
    Arthritis Res Ther; 2019 May; 21(1):112. PubMed ID: 31060598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Check-control of inflammation displayed by bone marrow mesenchymal stem cells in rheumatoid arthritis patients.
    Lamas JR; Mucientes A; Lajas C; Fernández-Gutiérrez B; Lópiz Y; Marco F; Jover JA; Abásolo L; Rodriguez-Rodriguez L
    Immunotherapy; 2019 Sep; 11(13):1107-1116. PubMed ID: 31378114
    [No Abstract]   [Full Text] [Related]  

  • 3. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
    Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
    Front Immunol; 2020; 11():54. PubMed ID: 32117234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Wharton's jelly mesenchymal stem cells maintain the expression of key immunomodulatory molecules when subjected to osteogenic, adipogenic and chondrogenic differentiation in vitro: new perspectives for cellular therapy.
    La Rocca G; Lo Iacono M; Corsello T; Corrao S; Farina F; Anzalone R
    Curr Stem Cell Res Ther; 2013 Jan; 8(1):100-13. PubMed ID: 23317435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis.
    Sarsenova M; Issabekova A; Abisheva S; Rutskaya-Moroshan K; Ogay V; Saparov A
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells.
    Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM
    Cytokine; 2016 Sep; 85():51-60. PubMed ID: 27288632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Mesenchymal Stromal Cells/Pericytes (MSCs) With Pulsed Electromagnetic Field (PEMF) Has the Potential to Treat Rheumatoid Arthritis.
    Ross CL; Ang DC; Almeida-Porada G
    Front Immunol; 2019; 10():266. PubMed ID: 30886614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trained murine mesenchymal stem cells have anti-inflammatory effect on macrophages, but defective regulation on T-cell proliferation.
    Lin T; Pajarinen J; Kohno Y; Huang JF; Maruyama M; Romero-Lopez M; Nathan K; Yao Z; Goodman SB
    FASEB J; 2019 Mar; 33(3):4203-4211. PubMed ID: 30521384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory Effects of Human Adipose Tissue-derived Mesenchymal Stem Cells on T Cell Subsets in Patients with Rheumatoid Arthritis.
    Baharlou R; Rashidi N; Ahmadi-Vasmehjani A; Khoubyari M; Sheikh M; Erfanian S
    Iran J Allergy Asthma Immunol; 2019 Feb; 18(1):114-119. PubMed ID: 30848580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory Effects of MSCs in Bone Healing.
    Medhat D; Rodríguez CI; Infante A
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31684035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
    El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
    Front Immunol; 2021; 12():643170. PubMed ID: 33732263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human adipose tissue-derived mesenchymal stem cells in rheumatoid arthritis: Regulatory effects on peripheral blood mononuclear cells activation.
    Baharlou R; Ahmadi-Vasmehjani A; Faraji F; Atashzar MR; Khoubyari M; Ahi S; Erfanian S; Navabi SS
    Int Immunopharmacol; 2017 Jun; 47():59-69. PubMed ID: 28364628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
    De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
    Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New concepts on the immune modulation mediated by mesenchymal stem cells.
    Bunnell BA; Betancourt AM; Sullivan DE
    Stem Cell Res Ther; 2010 Nov; 1(5):34. PubMed ID: 21092149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of CD200/CD200R1 Immunomodulatory Axis of Allogenic Peripheral Blood Mononuclear Cells in a Co-culture with Adipose-derived Mesenchymal Stem Cells.
    Heidari N; Mohammadi M; Rezaee MA; Amini AA; Fakhari S; Rahmani MR
    Iran J Allergy Asthma Immunol; 2020 Oct; 19(5):484-496. PubMed ID: 33463116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citrullinated fibrinogen impairs immunomodulatory function of bone marrow mesenchymal stem cells by triggering toll-like receptor.
    Sun Y; Deng W; Yao G; Chen W; Tang X; Feng X; Lu L; Sun L
    Clin Immunol; 2018 Aug; 193():38-45. PubMed ID: 29373844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists.
    Tomic S; Djokic J; Vasilijic S; Vucevic D; Todorovic V; Supic G; Colic M
    Stem Cells Dev; 2011 Apr; 20(4):695-708. PubMed ID: 20731536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis.
    Kastrinaki MC; Sidiropoulos P; Roche S; Ringe J; Lehmann S; Kritikos H; Vlahava VM; Delorme B; Eliopoulos GD; Jorgensen C; Charbord P; Häupl T; Boumpas DT; Papadaki HA
    Ann Rheum Dis; 2008 Jun; 67(6):741-9. PubMed ID: 17921184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
    Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C
    Vet Immunol Immunopathol; 2016 Mar; 171():57-65. PubMed ID: 26964718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.